Skip to main content
Open Biology logoLink to Open Biology
. 2022 Dec 21;12(12):220322. doi: 10.1098/rsob.220322

Characterization of insulin crystalline form in isolated β-cell secretory granules

Seiya Asai 1,2,, Jana Moravcová 3,, Lenka Žáková 1, Irena Selicharová 1, Romana Hadravová 1, Andrzej Marek Brzozowski 4, Jiří Nováček 3,, Jiří Jiráček 1,
PMCID: PMC9768635  PMID: 36541100

graphic file with name rsob220322.thumb.jpg

Keywords: crystallization in vivo, peptide hormone, subcellular vesicle, electron microscopy, secretory granules, insulin secretion

Abstract

Insulin is stored in vivo inside the pancreatic β-cell insulin secretory granules. In vitro studies have led to an assumption that high insulin and Zn2+ concentrations inside the pancreatic β-cell insulin secretory granules should promote insulin crystalline state in the form of Zn2+-stabilized hexamers. Electron microscopic images of thin sections of the pancreatic β-cells often show a dense, regular pattern core, suggesting the presence of insulin crystals. However, the structural features of the storage forms of insulin in native preparations of secretory granules are unknown, because of their small size, fragile character and difficult handling. We isolated and investigated the secretory granules from MIN6 cells under near-native conditions, using cryo-electron microscopic (Cryo-EM) techniques. The analysis of these data from multiple intra-granular crystals revealed two different rhomboidal crystal lattices. The minor lattice has unit cell parameters (ab ≃ 84.0 Å, c ≃ 35.2 Å), similar to in vitro crystallized human 4Zn2+-insulin hexamer, whereas the largely prevalent unit cell has more than double c-axis (abc ≃ 96.5 Å) that probably corresponds to two or three insulin hexamers in the asymmetric unit. Our experimental data show that insulin can be present in pancreatic MIN6 cell granules in a microcrystalline form, probably consisting of 4Zn2+-hexamers of this hormone.

1. Introduction

Insulin is a small protein hormone that is essential for the uptake of blood glucose to muscle and adipose tissues. Insulin is produced in β-cells of the pancreatic Islets of Langerhans, synthesized firstly in endoplasmic reticulum as 110 amino acids preproinsulin. Subsequently, the preproinsulin's N-terminal signal sequence is cleaved and a single-chain 81 amino acid proinsulin is transported into the Golgi apparatus, where it is folded and stored in newly formed insulin storage granules [1]. It has been suggested that in Zn2+-rich secretory granules, single-chain proinsulin forms Zn2+-stabilized soluble hexamers [2]. Finally, specific convertases cleave out proinsulin's C-peptide to produce mature double-chain insulin that should still be present in the form of Zn2+-hexamer [36]. Insulin has low solubility at the mildly acidic pH that is in the secretory granules, which should accelerate the conversion from proinsulin and protect mature insulin from proteolysis. Moreover, it has been proposed that the high concentration of zinc ions and insulin in granules, and lower solubility of this hormone in this environment should promote aggregation, precipitation and crystallization of Zn2+-stabilized insulin hexamers stored in secretory granules in vivo [2,79].

The breakthrough in structural investigations of insulin was provided by Dorothy M. Crowfoot Hodgkin's group in 1969 [10]. They crystallized and solved the structure of the rhombohedral crystals of 2Zn pig insulin hexamer, paving the way for hundreds of in vitro structures of human insulin, its analogues and insulins from other species. It is known that different types of insulin hexamers, referred to as T6, T3Rf3 and R6, depending on the conformation of insulin monomers forming the hexamer, can exist in vitro [6,11]. Insulin monomers can differ by the conformation of the B1–B6 residues of the B-chain. In the T conformation of insulin, residues B1–B6 are in an extended conformation, followed by a B7–B10 type II’ β-strand, followed by an invariant B9–B19 α-helix. In the presence of higher concentrations of small aromatic alcohols, such as phenol [1214], the B1–B6 segment of insulin can adopt the α helical conformation, called the R state. At higher concentrations of SCN, Cl or Zn2+ ions [15], or lower concentrations of cyclic alcohols [13,14,16], the long helix B in the R state shortens to the B3–B19 segment, and the B1–B3 residues ‘fray’ apart, giving what is called the Rf form of insulin. The specific type of insulin conformation in the hexamer can also be induced in vitro by the presence of neurotransmitters [17] or arginine [18], which are expected to be present in the granules [1922]. Particular forms of the insulin hexamers in vitro give them characteristic thermodynamic stabilities [23,24]. Therefore, a specific type of crystalline insulin oligomer in the secretory granules may have an impact on the biodynamics of the insulin secretion process, and, ultimately, the bioavailability of the hormone in vivo.

Protein crystals in the living organism have always attracted the attention of the scientific community. The presence of crystalline materials in vivo inside cells, in cellulo, is rather a rare phenomenon, but has been known for several decades, with initial reports dating back to the nineteenth century when protein crystals in human tissue [25] and plant seeds [26] were first described. In general, aggregation or crystallization of proteins inside cells may have a detrimental effect on cells' viability and, hence, evolution favours soluble or membrane-anchored proteins [27]. Nevertheless, a fraction of proteins crystallizes in cells and their crystals can have functional consequences (see, for example, a review by Schönherr et al. [28]). However, only a few natively in cellulo crystallized proteins were detected in humans with, interestingly, all of them being linked to some pathological state. Accumulation of crystalline protein in the cytoplasm of histiocytes is associated with the crystal-storing histiocytosis [29]. Eye cataract can be caused by mutations in γD crystallin that is prone to aggregation and crystallization in the lens [30]. Abnormal crystallization of mutated haemoglobin C in erythrocytes is known to cause haemolytic anaemia [31]. Charcot–Leyden crystals [25] are formed by galectin-10 crystallization in human tissues and are considered as a hallmark of inflammatory disorders [32]. Hexagonal Reinke crystals [33,34] are of unclear molecular nature. They are usually located within the cytoplasm of Leydig cells in the human testis and are considered for the diagnosis of tumours [35]. In a wide variety of neuromuscular diseases, crystalline inclusions of mitochondrial creatine kinase [36] represent a marked feature in the mitochondrial intermembrane space of skeletal muscle fibres.

Therefore, if insulin is indeed stored in a crystalline form in the β-cells of pancreatic Islets of Langerhans, it would represent a unique example of the functionally beneficial role of in vivo protein crystallization in the human body.

Regular objects reminiscent of microcrystals were already observed in pancreatic β-cell insulin secretory granules in the 1960s (e.g. [7] and [37] for a review). The first attempts to characterize crystalline insulin in secretory granules of the grass snake were made in the early 1970s by Lange et al. [3840], based on the three-dimensional reconstruction from serial sections of the snake pancreatic tissue, and by optical diffraction. They found that snake pancreatic granules contain particles in the shape of rhombic dodecahedra. In 1978, Raška et al. [41] used similar electron microscopic techniques for an ultrastructural analysis of β-cell granules from the Langerhans Islets of the alligator. They identified four distinct morphological types of crystalline inclusions: rhombohedron, rhomb-dodecahedron, dipyramid and prism. While the first three types of crystals were attributed to insulin, prismatic crystals were similar to those of proinsulin crystallized in vitro [42]. These early studies provided a strong argument that insulin can be stored in the pancreas in a crystalline form. However, as the examined samples were prepared from tissues that were firstly fixed with glutaraldehyde and osmium tetroxide, dehydrated with alcohol and embedded in epoxy resin, it cannot be excluded that such harsh sample conditions affected these reported structural forms of insulin.

Indications that insulin may be present in the pancreas in a crystalline form prompted us firstly to study the quaternary structures of insulin in native secretory granules, using advances of X-ray synchrotron bright source. However, we were not able to register any X-ray diffraction from the isolated secretory granules from rat pancreatic Islets of Langerhans and from rat INS-1E cells. Nevertheless, X-ray fluorescence (XRF) scans revealed a striking difference in Zn2+ content between INS-1E secretory granules and native rat pancreatic Islet granules [43].

Herein, we expand the analyses of the content of isolated insulin secretory granules by the application of electron cryo-microscopic techniques that provide a unique opportunity for the structural analysis of a single insulin storage granule particle under near-native conditions. We have been able to characterize the crystal unit cells of crystalline insulin in native granule preparations and show that the shape and dimensions are in accordance with the size of some insulin hexamers determined from crystals of this hormone prepared in vitro.

2. Results and discussion

In the first stages of this study, we searched for the optimum material for the isolation of insulin secretory granules and for further structural analyses. The selection of the material was dictated by the need for the most native-like source of insulin secretory granules, but also for their most feasible and ethical source. Animal pancreatic tissue represents the most native-like source, but the isolation of a sufficient number of granules demands sacrificing dozens of animals, followed by challenging and expensive isolation methodology which requires disintegration of this tissue with large amounts of a collagenase [43]. Moreover, the final granule preparation from Islets of Langerhans is inevitably contaminated by secretory granules from other types of cells, e.g. glucagon-producing α-cells or somatostatin-producing δ-cells [44]. Therefore, we had to consider different permanent cultured β-cell lines, and their comparative evaluation, e.g. morphology and number of granules and ability to produce and secrete insulin, and, for further experiments, we selected the clonal BRIN-BD11 and INS-1E β-cell lines and insulinoma-derived MIN6 β-cells, all of them of rodent origin.

2.1. Comparison of permanent cell lines by focused ion beam/scanning electron microscopy microscopy

The comparison of insulin secretory granules in all studied permanent pancreatic cell lines was carried out using serial focused ion beam/scanning electron microscopy (FIB/SEM) microscopy, which allowed the automated acquisition of high-resolution three-dimensional data. Here, we were able to gradually image, and very efficiently reconstruct, the three-dimensional volume of the whole pancreatic β-cells, or part of their volume, and to evaluate the appearance of the granules and their content in the whole β-cell. Ultimately, this allowed us a comparison of different β-cell lines within the broader context of their morphology.

We reconstructed and segmented whole pancreatic cells from the FIB/SEM data (electronic supplementary material, videos S1–S3), identified insulin secretory granules, and compared their populations among the studied cell lines in terms of number and size (figure 1). BRIN-BD11 cells clearly have a less dense population of insulin secretory granules, while INS-1E and MIN6 cells have a comparable number of granules per cell. We found that the apparent average size of granules (including the envelope) and insulin particles inside the granules is smaller in BRIN-BD11 (146 ± 22 nm and 94 ± 10 nm, respectively) than in INS-1E (238 ± 43 nm and 157 ± 33 nm) and MIN6 (250 ± 29 nm and 142 ± 12 nm) cells, which have a similar size of granules (figure 2).

Figure 1.

Figure 1.

FIB/SEM microscopy images of the segmented examined β-cells. Images (a) (INS-1E), (b) (MIN6) and (c) (BRIN-BD11) show segmented cells where only nuclei (in red) and insulin secretory granules (in green) were visualized and segmented out from the context of the whole cell volume. Images (d) (INS-1E), (e) (MIN6) and (f) (BRIN-BD11) show scanning electron microscopy images of segmented cells contrasted by uranyl acetate and osmium tetroxide. Yellow arrows point at insulin secretory granules enveloped with a membrane vesicle. Blue arrows show nuclear envelope, green arrows point at mitochondria and red arrows show Golgi apparatus inside of the cell cytosol. Brown arrows point to the endoplasmic reticulum visible in INS-1E and BRIN-BD11 cells and the orange arrow points to a BRIN-BD11 cell ribosome.

Figure 2.

Figure 2.

Magnified SEM images of typical secretory granules in the examined cell lines: (a) INS-1E, (b) MIN6 and (c) BRIN-BD11 cells.

In our other recent studies, we analysed the total insulin content in BRIN-BD11, INS-1E and MIN6 cells and in rat Langerhans Islets, and the insulin secretory properties of INS-1E and MIN6 cells after stimulation with glucose and different secretagogues [45]. This revealed that MIN6 cells are more glucose-responsive than INS-1E cells, both in terms of the quantity of secreted insulin and the reproducibility of results, despite a lower total insulin content in these cells. It is possible that the ability of INS-1E cells to secrete insulin in response to glucose is altered, possibly by an impaired proinsulin processing [43], and that higher intracellular concentration of (pro)insulin in INS-1E cells is caused by their reduced ability to secrete insulin. Therefore, considering all these results, and the initial analysis of the β-cells by FIB/SEM microscopy performed here, we selected the MIN6 cells for further isolation and analysis of insulin secretory granules, as they appear as a more native-like model of the β-cells than INS-1E or BRIN-BD11 cells.

2.2. Transmission electron microscopy (TEM) of insulin secretory granules from MIN6 cells

The insulin secretory granules from MIN-6 cells were isolated according to our protocol, described earlier by Dzianova et al. [43], and TEM images of isolated MIN6 cell secretory granules were collected (figure 3). Smaller particles representing insulin secretory granules were visible there (figure 3a–c), together with bigger mitochondria that were apparently copurified with insulin granules, a phenomenon already described by Brunner et al. [46]. They further optimized their purification protocol, extending it for an additional series of gradient centrifugations [47], as the presence of mitochondrial proteins would interfere with proteomics analyses of secretory granules. However, for our purpose here, the cryo-electron microscopy (Cryo-EM) and cryo-electron tomography (Cryo-ET) analyses of secretory granules, the presence of mitochondria in preparations did not represent any methodological problem. The TEM images showed (figure 3b) that some granules have an intact membrane, while other insulin-containing particles lack, completely or partially, their envelope, possibly due to damage during fractionation of the cells. It also seems that insulin particles without envelopes are still able to maintain their shape, even if some of them seem to be partly ‘dissolving’ (figure 3c).

Figure 3.

Figure 3.

TEM images of isolated insulin secretory granule fraction from MIN6 cells. In (a–c), granule preparation is shown at three different magnifications (bars indicate 2 µm, 500 nm and 200 nm, respectively). Yellow arrows show different forms of granules (with or without the envelope), white arrows point to mitochondria. (d) An image of negative stained secretory granules having an intact envelope. Insulin particles are in dark objects inside of envelopes. The bar indicates 500 nm.

2.3. Cryo-EM analyses of insulin secretory granules isolated from MIN6 cells

The Cryo-EM imaging of the isolated granules showed dense globular objects with diameter 129–303 nm and average size of 198 ± 41 nm (based on analysis of 35 dense core particles), and with a clearly visible regular arrangement (figure 4). The crystalline cores observed by Cryo-EM are about 30% larger than the dimensions obtained from FIB/SEM data (see above). We attribute this difference to a significantly larger pixel size in the case of FIB/SEM experiments (3 nm with respect to 1.34 Å for Cryo-EM data) and thus lower precision of the distance measurement, and partly also due to the sample compression during embedding. The crystalline-like centres of the granules were either membrane-free (figure 4a) or encapsulated in the membrane (figure 4b). These differences (i.e. dense core only versus whole granule) are probably due to the osmotic or mechanical pressure during sample vitrification, as the residual traces of membrane in close proximity to the insulin-containing core were frequently observed.

Figure 4.

Figure 4.

Cryo-EM images of the purified MIN6 cells insulin granules. Only the granule dense core is present in (a), whereas the whole granule is shown in (b). The bar corresponds to 100 nm in both insets.

Encouraged by the crystalline-like character of the granular core, we attempted the collection of the continuous rotation electron diffraction tomography (EDT) data, to determine the insulin structure in this crystalline lattice. However, this experiment was hampered by the small size of the crystalline cores. More importantly, we did not observe reflection peaks beyond approximately 5 Å, even in the static images. Therefore, we subsequently focused on the analysis of the low-resolution diffraction to determine the unit cell parameters of these crystalline cores. Here, we either collected discontinuous EDT data (electronic supplementary material, video S4) within ±40° tilt range (with 2° step) and image tracking step after every tilt. In addition, we also collected Cryo-ET data (electronic supplementary material, video S5) within the same tilt range as the EDT data, aligned the tilt series, and calculated the power spectra from the region containing the dense core. The data analysis relied only on the directions of the reflections, not on the precise determination of their intensities. In total, we analysed 20 granule dense cores and found that, in 19 cases, the crystals form a rhombohedral lattice with unit cell dimensions abc ≃ 96.5 Å, α ≃ 90°, βγ ≃ 120°, whereas, in the last case, the parameters of the rhombohedral lattice were ab ≃ 84.0 Å, c ≃ 35.2 Å, αβ ≃ 90°, γ ≃ 120°. The latter, smaller lattice is in good agreement with the lattice parameters of human 4 Zn2+-insulin hexamers (a = b = 80.953 Å, c = 37.636 Å) crystallized in vitro, analysed by X-ray diffraction and reported firstly in T3Rf3 form by Smith et al. [48], with one insulin hexamer in the asymmetric unit (AU) (space group R3).

However, the dimension of the c-axis is more than double for most of the crystals analysed here, which suggests that in cellulo larger packing assemblies of insulin hexamers are preferred over ‘individual’ hexamers. Assuming the R3 space group for this larger lattice, the Matthews coefficients which depict protein crystal Å3/Dalton parameter, typically approximately 2.4 Å3/Dalton for 47% crystal solvent content [49], would be 3.8 Å3/Dalton (approx. 68% solvent) for two hexamers in the crystal AU, and 2.5 Å3/Dalton—corresponding to approximately 51% solvent in the crystals for three hexamers/AU. If higher R32 trigonal symmetry is considered, Matthews coefficients' values would be 3.8 Å3/Dalton (approx. 68% solvent) for one hexamer/AU and 1.9 Å3/Dalton (approx. 35% solvent) for two hexamers/AU.

Given the size of the larger unit cell, insulin arrangement composed e.g. of two (or more) hexamers on top of each other as seen, for example, in the in vitro crystal structure by Murayoshi et al. (PDB: 3W80, a = b = 82.7 Å, c = 68.1 Å, αβ ≃ 90°, γ ≃ 120°) would explain the experimental data. Indeed, evidence of ‘dodecameric-like’ alligator insulin in microcrystals in cellulo was already provided earlier by Raška et al. [41]. In the insulin crystal structure by Murayoshi et al., the crystal lattice is formed by staggered columns of tightly packed (on top of each other) hexamers. Therefore, it can be envisaged here that a similar, tight two-hexamer basic packing unit, leading to a torus-like repeated hexamer column arrangement, can occur in the granules' lattice. This would ensure an additional level of stability, superior to a single insulin hexamer (or dimer) crystal packing motif, also prolonging the storage lifetime of insulin in vivo. This would be consistent with our findings that the crystalline insulin structure in isolated granules remained compact, even after loss of the granular envelope (figure 3). However, some other crystal packing arrangements involving, for example, three hexamers, cannot be excluded.

It is also tempting to consider here the T3Rf3 form of insulin storage hexamer that was found in vitro not only in the 4Zn2+ insulin oligomer [48], but also in insulin hexamers obtained in the presence of neurotransmitter serotonin [17] and proinsulin post-processing by-product arginine [18]. Both these T3Rf3 hexamer-stabilizing ligands are expected to be common components of insulin storage granules [1922]. However, the tight column-like packing of insulin hexamers in the Murayoshi et al. crystal structure (PDB: 3W80) has been allowed by the compact T6 form of these hexamers. Therefore, the expansion of this unit cell from in vitro approximately 68.1/82.7 Å to approximately 96.5 Å that is observed in the dominant granules’ crystal lattice found in this study, may result from a need to accommodate possible, and relatively bulkier, T3Rf3-like insulin hexamers.

Small amino acids’ sequence differences between mouse/rat insulin studied here and the human hormone (electronic supplementary material, figure S1) should not prevent the occurrence of similar tertiary and quaternary structures of both hormones.

The estimated unit cell parameters and the crystalline core size volume determined by Cryo-ET allow us to estimate that a single MIN6 cell granule can store approximately 60 000 insulin molecules, which is not too far from the 200 000 human insulin molecules per cell estimated much earlier in 1984 [50].

2.4. Cryo-FIBM and Cryo-ET analyses of cross-sections from MIN6 cells

Finally, we used cryo-focused ion beam micromachining (Cryo-FIBM) and Cryo-ET to visualize the granules in the cross-section of the MIN6 cell under near-native conditions. Similarly to the imaging of purified granules, we searched for the granule orientation where the high-symmetry axis was parallel to the beam direction. We found that the granular dense core in whole MIN6 cells indeed has a regular arrangement (figure 5), similar to isolated granules.

Figure 5.

Figure 5.

Crystalline core visualized in cellulo within insulin secretory granules of MIN6 cells. Cellular lamellae prepared by cryo-FIB depicting thin sections of MIN6 cells (a,c). Images from the cryo-ET tilt series showing a detailed view on the granule crystalline core alongside the zonal planes of the insulin crystals (b,d). Scale bars corresponds to 1 µm in (a) and (c) and 100 nm in (b) and (d).

3. Conclusion

We isolated insulin secretory granules from mouse β-cell-derived MIN6 cells under close-to-native conditions, to assure the minimum effect of the experimental conditions on the storage form of insulin in the granules. Employing Cryo-EM, we detected a three-dimensional regular arrangement in the dense core particles within the secretory granules, indicating the presence of crystalline material. We were able to identify two types of rhombohedral lattices in these microcrystals: a minor lattice with the unit cell dimensions ab ≃ 84.0 Å, c ≃ 35.2 Å, αβ ≃ 90°, γ ≃ 120°, and a highly predominant lattice form with the unit cell dimensions abc ≃ 96.5 Å, α ≃ 90°, βγ ≃ 120°. The minor form of the lattice corresponds relatively well to the presence of the hexameric 4Zn2+ insulin crystal form, hence possibly to the T3Rf3 hexamer of this hormone, while the major lattice form, with almost twice the length of the c-axis, indicates the presence of higher oligomeric packing of insulin forms, for example two toroidal hexamers on top of each other (pseudo ‘dodecamer’). Our findings clearly confirm previous assumptions that stored insulin is present in the cell in crystalline form, also providing unambiguous details on the in cellulo crystal lattice parameters, and its hexamer packing, characterized in the most native experimental conditions to date. Considering the current rapid developments in cell biology and cryo-microscopic imaging techniques, our findings could initiate new studies investigating, for example, the relationship between the type of insulin structural forms (e.g. crystalline or amorphous) in secretory granules and the ability of β-cells to secrete insulin.

4. Methods

4.1. Cell cultures and cell cultivation

The clonal β-cell line BRIN-BD11 (Sigma-Aldrich, Cat no. 10033003) is a hybrid line formed by electrofusion of a primary culture of rat pancreatic β-cells (New England Deaconess Hospital, NEDH) with RINm5F cells [51,52]. The cells were cultured in a humidified atmosphere containing 5% CO2 and at 37°C in a complete medium, composed of RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM l-glutamine, 10 mM HEPES, 100 U ml−1 penicillin and 100 U ml−1 streptomycin.

The rat clonal β-cell line INS-1E [53] (AddexBio, Cat no. C0018009) derived from parental INS-1 cells [54] was cultured in a humidified atmosphere containing 5% CO2 and at 37°C in a complete medium, composed of RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 1 mM sodium pyruvate, 50 mM 2-mercaptoethanol, 2 mM l-glutamine, 10 mM HEPES, 100 U ml−1 penicillin and 100 U ml−1 streptomycin.

Mouse insulinoma-derived MIN6 cells were a kind gift from the Miyazaki laboratory, Osaka University, Japan [55] and were cultivated in a complete medium, composed of DMEM high glucose medium, supplemented with 10% heat-inactivated FBS, 50 mM 2-mercaptoethanol, 2 mM l-glutamine, 100 U ml−1 penicillin and 100 U ml−1 streptomycin.

4.2. Cell fixation and resin embedding

Permanent pancreatic cells were cultivated until 80% confluency, collected, and pelleted by spinning at 500 g at 37°C. Each cell pellet was fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer saline (PBS), washed and mixed with 2% agar. The cell pellet in agar was fixed with 2% OsO4 in 0.1 M PBS, washed and soaked with 1% uranyl acetate. Stained cells were gradually dehydrated in 40–100% ethanol and transferred into propylenoxide. Both procedures were performed on ice. Propylenoxide was gradually exchanged with durcupan with constant shaking and the samples were allowed to polymerize 48 h at 60°C.

4.3. Resin sample processing and preparation for focused ion beam/scanning electron microscopy

Resin blocks with a cellular sample were roughly cut out by a razor blade and fixed on the top of the electron microscope stub. Resin cellular blocks were trimmed, and the block face gently smoothed with a glass knife on ultramicrotome. The smoothened cellular blocks (10 nm) were sputtered with 10 nm of inorganic gold.

4.4. Serial section electron microscopy

The Helios 4 DualBeam FIB–SEM microscope (Thermo Fisher Scientific), equipped with backscattered electron in-column detector (ICD) and Auto Slice and View software (Thermo Fisher Scientific), was used for collection of raw serial section electron microscopy (SSEM) data by a method of the alternation of thin specimen slice milling by focused gallium ion beam and high-resolution imaging of specimen face by electron beam.

The area of interest was covered with a 1–2 mm of organic platinum protective layer, created by the gas injection system (GIS). A fiducial marker for tracking and image alignment was created by milling of the cross-shape pattern into a 1–2 mm GIS rectangle protective layer.

The microscope stage was tilted to 52° to get the specimen face perpendicular to the ion beam source. The specimen block with dimensions: x = 20–30 µm, y = 20–30 µm and z = 10–20 µm was revealed by trenches' creation around three sides of the block (front, left and right). The trenches were created by FIB at 7 nA current. The block face for SEM imaging was smoothed by FIB current set in the range of 1.2–2.4 nA.

The following settings for SSEM imaging were defined: magnification ranged between 7K-fold and 9K-fold, image resolution was 3072 × 2048, dwell time was 6 ms, image pixel size ranged between 3 × 3 nm and 9 × 9 nm. Backscattered electrons were detected by ICD.

The following settings for FIB milling were defined: single slice thickness ranged from 10 to 20 nm, FIB current was set to 0.75 nA.

4.5. Data processing and segmentation of insulin granules in slices from cells

SSEM data collected in TIFF image format were semi-automatically aligned; the region of interest in xyz dimensions was extracted out of the dataset and the pancreatic cell nuclear envelope and visible insulin granules were segmented out and visualized in Amira software (Thermo Fisher Scientific). Next, on a sample of 30 secretory mature granules (with the insulin content separated from the envelope by a visible ‘halo’) in each of the cell types, BRIN-BD11, INS-1E and MIN6, we measured the average size (± s.d.) of the granules (including their envelope) and then the average size (± s.d.) of the insulin particles inside the granules. An example of the measurements in INS-1Es is shown in electronic supplementary material, figure S2.

4.6. Isolation of secretory granules from MIN6 cells

The isolation of granules was performed according to the protocol published by Brunner et al. [46] and described in detail in Dzianova et al. [43]. The final pellet of isolated insulin secretory granules was re-suspended in buffer composed of 0.27 M sucrose, 10 mM MOPS/1 M Tris, pH 6.8 (SMT buffer), kept at 0–4°C without freezing, and used for further analyses within the next 24 h.

The protein content in the granule fraction was determined by the Bradford assay. The proteins from isolated and lysed granules were separated on sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE) (12% gels) and checked by using the standard Western blotting procedure for insulin (anti-insulin antibody, L6B10, Cell Signalling) and betagranin (anti-chromogranin A antibody directed against N-terminal amino acids, ab45179, Abcam) content, according to Dzianova et al. [43] (electronic supplementary material, figure S3).

4.7. Chemical fixation and transmission electron microscopy of isolated insulin secretory granules from MIN6 cells

The fixation and examination of isolated granules were carried out as previously described in Dzianova et al. [43]. Briefly, the suspension of freshly isolated granules in SMT buffer was fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.5) at room temperature (RT) for 15 min. Then the granule suspension was centrifuged at 120 g for 4 min. A new batch of 2.5% glutaraldehyde in 0.1 M cacodylate buffer was added and then the pellets were post-fixed in 1% osmium tetroxide, dehydrated in ethanol and embedded in Agar 100 epoxy resin. Ultrathin sections (70 nm) were cut with a diamond knife on a Leica UC6 ultramicrotome (Leica Microsystems, Wetzlar, Germany). The ultrathin sections were collected on parlodion-coated microscopy grids and contrasted, using saturated uranyl acetate and lead citrate. The isolated granules were also negative stained with 2% sodium phosphotungstate on parlodion-carbon-coated grids. The samples were analysed with the transmission electron microscope JEOL JEM-1011 device at 80 kV beam acceleration voltage.

4.8. Preparation of insulin secretory granules isolated from MIN6 cells for Cryo-EM

The suspension of freshly isolated MIN6 granules in SMT buffer (kept strictly at 0–4°C) was applied to the freshly plasma-cleaned holey carbon TEM grids (Quantifoil, Cu, 200 mesh, R2/1) and vitrified by plunge freezing into liquid ethane, using Vitrobot IV (ThermoScientific). The sample was incubated for 30 s on the grid in the instrument climate chamber (4°C, 100% rel. humidity) with prior blotting from both sides with filter paper. The grids with vitrified specimens were transferred to liquid nitrogen, mounted into the Autogrid cartridge and loaded into the transmission electron microscope for imaging.

4.9. Cryo-focused ion beam preparation of lamellas from MIN6 cells for Cryo-TM

Freshly plasma-cleaned holey carbon TEM grids (Quantifoil, Au, 200 mesh, R2/2) were placed into 10 mm cultivation wells (ThermoScientific) and supplemented with 100 ml of cell suspension, containing approximately 10 000 MIN6 cells. The wells were placed into the incubator (37°C, 5% CO2) for 16 h to allow adhesion of MIN6 cell to the grid surface. Subsequently, the grids were transferred to Vitrobot IV, blotted against non-absorptive blotting material, and vitrified into liquid ethane. The grids were mounted into the AutoGrid cartridge and loaded into the Versa 3D FIB/SEM microscope (ThermoScientific) for lamella preparation. Cells positioned close to the centre of the grid square were selected for lamella preparation by FIB. The sample surface was coated with a protective layer of metallo-organic platinum (GIS) and sputter coated with iridium. The lamella was prepared by gradual milling from both sides, with gradual decrease of the distance between the milling patterns and the milling current. The final polishing step was carried out with 10 pA milling current and was used to refine the lamella to 150–250 nm thickness. The grid was then transferred to the transmission electron microscope for Cryo-ET.

4.10. Cryo-TEM imaging

The cryo-transmission electron microscopy (Cryo-TEM) data were collected, using either Talos Arctica (operated at 200 kV) or Titan Krios (operated at 300 kV) transmission electron microscopes (ThermoScientific). The microscopes were equipped with post-column energy filter (Gatan) and K2, or K3, respectively, (Gatan) direct electron detector cameras. Single Cryo-TEM images of purified granules were collected with the overall dose less than 15 e/A2. The Cryo-ET and discontinuous EDT data were collected using SerialEM software. The acquisition of the tilt series was started at −40° stage tilt and the stage were incrementally rotated by 2° until +40° stage tilt. The overall dose per tilt series did not exceed 15 e/A2. Cryo-ET data were collected with defocus of −0.5 µm or −2.5 µm, respectively. The acquired frames were first corrected for the drift and beam-induced motion MotionCor2 (PMID: 28250466); contrast transfer function parameters were estimated using the GCTF program (PMID: 26592709), and the tilt series alignment and tomogram reconstruction were carried out in Imod. The granule dense core was cropped from the aligned tilt series collected with −0.5 µm, Fourier transformed, and the resulting power spectra were converted to SMV file format, using the in-house Python script for further processing in X-ray detection software (XDS). EDT data were collected on the K3 camera, operated in counting mode as single images per individual tilt angles. The resulting tilt series was first rotated in imod, to align the tilt axis with the image y-axis and cropped to square images. Subsequent data analysis to determine the unit cell parameters was carried out in XDS.

Contributor Information

Jiří Nováček, Email: jiri.novacek@ceitec.muni.cz.

Jiří Jiráček, Email: jiracek@uochb.cas.cz.

Data accessibility

The data are provided in electronic supplementary material [56].

Authors' contributions

S.A.: formal analysis, investigation, methodology, writing—review and editing; J.M.: data curation, formal analysis, investigation, methodology, validation, visualization, writing—review and editing; L.Ž.: conceptualization, data curation, formal analysis, investigation, methodology, validation, writing—review and editing; I.S.: data curation, formal analysis, investigation, methodology, validation, writing—review and editing; R.H.: formal analysis, methodology, writing—review and editing; A.M.B.: conceptualization, validation, writing—review and editing; J.N.: conceptualization, data curation, formal analysis, investigation, methodology, validation, writing—original draft, writing—review and editing; J.J.: conceptualization, data curation, formal analysis, validation, writing—original draft, writing—review and editing.

All authors gave final approval for publication and agreed to be held accountable for the work performed therein.

Conflict of interest declaration

The authors declare that there are no conflicts or competing interests.

Funding

The research was supported by the European Regional Development Fund; OP RDE; Project: Chemical biology for drugging undruggable targets (ChemBioDrug) (no. CZ.02.1.01/0.0/0.0/16_019/0000729, to J.J.). Institutional support was provided by project RVO 61388963 (to the Institute of Organic Chemistry and Biochemistry) of the Czech Academy of Sciences. A.M.B. was supported by MRC grant MR/R009066/1 and BBSRC grant BB/W003783/1. We acknowledge the Cryo-electron Microscopy and Tomography core facility CEITEC MU of CIISB, Instruct-CZ Centre supported by MEYS CR (LM2018127). J.N. and J.M. acknowledge the support from ThermoFisher Scientific Brno, Czech Republic.

References

  • 1.Orci L, Ravazzola M, Amherdt M, Madsen O, Vassalli JD, Perrelet A. 1985. Direct identification of prohormone conversion site in insulin-secreting cells. Cell 42, 671-681. ( 10.1016/0092-8674(85)90124-2) [DOI] [PubMed] [Google Scholar]
  • 2.Dodson G, Steiner D. 1998. The role of assembly in insulin's biosynthesis. Curr. Opin. Struct. Biol. 8, 189-194. ( 10.1016/s0959-440x(98)80037-7) [DOI] [PubMed] [Google Scholar]
  • 3.Steiner DF, Park SY, Stoy J, Philipson LH, Bell GI. 2009. A brief perspective on insulin production. Diabetes Obes. Metab. 11, 189-196. ( 10.1111/j.1463-1326.2009.01106.x) [DOI] [PubMed] [Google Scholar]
  • 4.Foster MC, Leapman RD, Li MX, Atwater I. 1993. Elemental composition of secretory granules in pancreatic-islets of Langerhans. Biophys. J. 64, 525-532. ( 10.1016/S0006-3495(93)81397-3) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Emdin SO, Dodson GG, Cutfield JM, Cutfield SM. 1980. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia 19, 174-182. ( 10.1007/BF00275265) [DOI] [PubMed] [Google Scholar]
  • 6.Weiss MA. 2009. The structure and function of insulin: decoding the TR transition. In Vitamins and hormones. Insulin and IGFs (ed. Litwack G), pp. 33-49. London, UK: Elsevier. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Greider MH, Howell SL, Lacy PE. 1969. Isolation and properties of secretory granules from rat islets of Langerhans. II. Ultrastructure of the beta granule. J. Cell Biol. 41, 162-166. ( 10.1083/jcb.41.1.162) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dodson EJ, Dodson GG, Hodgkin DC, Reynolds CD. 1979. Structural relationships in the two-zinc insulin hexamer. Can. J. Biochem. 57, 469-479. ( 10.1139/o79-060) [DOI] [PubMed] [Google Scholar]
  • 9.Michael J, Carroll R, Swift HH, Steiner DF. 1987. Studies on the molecular organization of rat insulin secretory granules. J. Biol. Chem. 262, 16 531-16 535. [PubMed] [Google Scholar]
  • 10.Adams MJ, et al. 1969. Structure of rhombohedral 2 Zinc insulin crystals. Nature 224, 491-495. ( 10.1038/224491a0) [DOI] [Google Scholar]
  • 11.Kosinova L, et al. 2014. Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin. Biochemistry 53, 3392-3402. ( 10.1021/Bi500073z) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Smith GD, Dodson GG. 1992. The structure of a rhombohedral R6 insulin hexamer that binds phenol. Biopolymers 32, 441-445. ( 10.1002/bip.360320422) [DOI] [PubMed] [Google Scholar]
  • 13.Whittingham JL, Chaudhuri S, Dodson EJ, Moody PC, Dodson GG. 1995. X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. Biochemistry 34, 15 553-15 563. ( 10.1021/bi00047a022) [DOI] [PubMed] [Google Scholar]
  • 14.Smith GD, Ciszak E, Pangborn W. 1996. A novel complex of a phenolic derivative with insulin: structural features related to the T–>R transition. Protein Sci. 5, 1502-1511. ( 10.1002/pro.5560050806) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Brzovic PS, Choi WE, Borchardt D, Kaarsholm NC, Dunn MF. 1994. Structural asymmetry and half-site reactivity in the T to R allosteric transition of the insulin hexamer. Biochemistry 23, 13 057-13 069. ( 10.1021/bi00248a015) [DOI] [PubMed] [Google Scholar]
  • 16.Smith GD, Dodson GG. 1992. Structure of a rhombohedral R6 insulin/phenol complex. Proteins 14, 401-408. ( 10.1002/prot.340140309) [DOI] [PubMed] [Google Scholar]
  • 17.Palivec V, et al. 2017. Computational and structural evidence for neurotransmitter-mediated modulation of the oligomeric states of human insulin in storage granules. J. Biol. Chem. 292, 8342-8355. ( 10.1074/jbc.M117.775924) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Brezina K, Duboue-Dijon E, Palivec V, Jiracek J, Krizek T, Viola CM, Ganderton TR, Brzozowski AM, Jungwirth P. 2018. Can arginine inhibit insulin aggregation? A combined protein crystallography, capillary electrophoresis, and molecular simulation study. J. Phys. Chem. B 122, 10 069-10 076. ( 10.1021/acs.jpcb.8b06557) [DOI] [PubMed] [Google Scholar]
  • 19.Falck B, Hellman B. 1963. Evidence for the presence of biogenic amines in pancreatic islets. Experientia 19, 139-140. ( 10.1007/BF02171596) [DOI] [Google Scholar]
  • 20.Ericson LE, Hakanson R, Lundquist I. 1977. Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 13, 117-124. ( 10.1007/BF00745138) [DOI] [PubMed] [Google Scholar]
  • 21.Lundquist I, Ekholm R, Ericson LE. 1971. Monoamines in the pancreatic islets of the mouse. 5-Hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors. Diabetologia 7, 414-422. ( 10.1007/BF01212056) [DOI] [PubMed] [Google Scholar]
  • 22.Davidson HW. 2004. (Pro)Insulin processing: a historical perspective. Cell Biochem. Biophys. 40, 143-158. ( 10.1385/cbb:40:3:143) [DOI] [PubMed] [Google Scholar]
  • 23.Lisi GP, Png CYM, Wilcox DE. 2014. Thermodynamic contributions to the stability of the insulin hexamer. Biochemistry 53, 3576-3584. ( 10.1021/bi401678n) [DOI] [PubMed] [Google Scholar]
  • 24.Hassiepen U, Federwisch M, Mulders T, Wollmer A. 1999. The lifetime of insulin hexamers. Biophys. J. 77, 1638-1654. ( 10.1016/S0006-3495(99)77012-8) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Charcot JM, Robin C. 1853. Observation of leukocytosis. C. R. Mem. Soc. Biol. 5, 450-454. [Google Scholar]
  • 26.Hartig T. 1855. About the gluten flour. Bot. Zeitung 13, 881. [Google Scholar]
  • 27.Doye JP, Louis AA, Vendruscolo M. 2004. Inhibition of protein crystallization by evolutionary negative design. Phys. Biol. 1, P9-P13. ( 10.1088/1478-3967/1/1/P02) [DOI] [PubMed] [Google Scholar]
  • 28.Schonherr R, Rudolph JM, Redecke L. 2018. Protein crystallization in living cells. Biol. Chem. 399, 751-772. ( 10.1515/hsz-2018-0158) [DOI] [PubMed] [Google Scholar]
  • 29.Dogan S, Barnes L, Cruz-Vetrano WP. 2012. Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification. Head Neck Pathol. 6, 111-120. ( 10.1007/s12105-011-0326-3) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King J, Benedek GB. 2001. Crystal cataracts: human genetic cataract caused by protein crystallization. Proc. Natl Acad. Sci. USA 98, 6116-6120. ( 10.1073/pnas.101124798) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lawrence C, Fabry ME, Nagel RL. 1991. The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood 78, 2104-2112. [PubMed] [Google Scholar]
  • 32.Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR. 2002. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J. Biol. Chem. 277, 14 859-14 868. ( 10.1074/jbc.M200221200) [DOI] [PubMed] [Google Scholar]
  • 33.Reinke F. 1896. Contributions to the human histology. I. About the formation of crystalloids in interstitial cells of the human testis. Arch. Mikrosk. Anat. 47, 34-44. [Google Scholar]
  • 34.Planinic A, Maric T, Bojanac AK, Jezek D. 2022. Reinke crystals: hallmarks of adult Leydig cells in humans. Andrology 10, 1107-1120. ( 10.1111/andr.13201) [DOI] [PubMed] [Google Scholar]
  • 35.Jain M, Aiyer HM, Bajaj P, Dhar S. 2001. Intracytoplasmic and intranuclear Reinke's crystals in a testicular Leydig-cell tumor diagnosed by fine-needle aspiration cytology: a case report with review of the literature. Diagn. Cytopathol. 25, 162-164. ( 10.1002/dc.2029) [DOI] [PubMed] [Google Scholar]
  • 36.Smeitink J, Stadhouders A, Sengers R, Ruitenbeek W, Wevers R, ter Laak H, Trijbels F. 1992. Mitochondrial creatine kinase containing crystals, creatine content and mitochondrial creatine kinase activity in chronic progressive external ophthalmoplegia. Neuromuscul. Disord. 2, 35-40. ( 10.1016/0960-8966(92)90024-z) [DOI] [PubMed] [Google Scholar]
  • 37.Lange RH. 1973. Histochemistry of the Islets of Langerhans. Stuttgart, Germany: Gustav Fischer Verlag. [Google Scholar]
  • 38.Lange RH. 1971. Crystalline B-granules: rhombic dodecaheders (a = 7.4 nm?). Diabetologia 7, 465-466. ( 10.1007/BF01212065) [DOI] [PubMed] [Google Scholar]
  • 39.Lange RH, Boseck S, Ali SS. 1972. Kristallographische Interpretation der Feinstruktur der B-granula in der Langerhansschen Inseln der Ringelnatter, Natrix n. natrix (L.). Z. Zellforsch. 131, 559-570. [PubMed] [Google Scholar]
  • 40.Lange RH. 1974. Crystalline islet B-granules in the grass snake (Natrix natrix (L.)): tilting experiments in the electron microscope. J. Ultrastruct. Res. 46, 301-307. ( 10.1016/s0022-5320(74)80064-x) [DOI] [PubMed] [Google Scholar]
  • 41.Raška I, Komrska J, Titlbach M, Rieder M. 1978. Fine structure of crystalline inclusions in B-cells of the islets of Langerhans in the alligator. Cell Tissue Res. 187, 535-550. ( 10.1007/BF00229618) [DOI] [PubMed] [Google Scholar]
  • 42.Fullerton WW, Potter R, Low BW. 1970. Proinsulin: crystallization and preliminary X-ray diffraction studies. Proc. Natl Acad. Sci. USA 66, 1213-1219. ( 10.1073/pnas.66.4.1213) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dzianova P, et al. 2020. The efficiency of insulin production and its content in insulin-expressing model beta-cells correlate with their Zn2+ levels. Open Biol. 10, 200137. ( 10.1098/rsob.200137) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gaisano HY, Macdonald PE, Vranic M. 2012. Glucagon secretion and signaling in the development of diabetes. Front. Physiol. 3, 349. ( 10.3389/fphys.2012.00349) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Asai S, Zakova L, Selicharova I, Jiracek J. 2021. A radioligand receptor binding assay for measuring of insulin secreted by MIN6 cells after stimulation with glucose, arginine, ornithine, dopamine, and serotonin. Anal. Bioanal. Chem. 413, 4531-4543. ( 10.1007/s00216-021-03423-3) [DOI] [PubMed] [Google Scholar]
  • 46.Brunner Y, Coute Y, Iezzi M, Foti M, Fukuda M, Hochstrasser DF, Wollheim CB, Sanchez JC. 2007. Proteomics analysis of insulin secretory granules. Mol. Cell. Proteom. 6, 1007-1017. ( 10.1074/mcp.M600443-MCP200) [DOI] [PubMed] [Google Scholar]
  • 47.Schvartz D, Brunner Y, Coute Y, Foti M, Wollheim CB, Sanchez JC. 2012. Improved characterization of the insulin secretory granule proteomes. J. Proteom. 75, 4620-4631. ( 10.1016/j.jprot.2012.04.023) [DOI] [PubMed] [Google Scholar]
  • 48.Smith GD, Swenson DC, Dodson EJ, Dodson GG, Reynolds CD. 1984. Structural stability in the 4-zinc human insulin hexamer. Proc. Natl Acad. Sci. USA 81, 7093-7097. ( 10.1073/pnas.81.22.7093) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Matthews BW. 1968. Solvent content of protein crystals. J. Mol. Biol. 33, 491-497. ( 10.1016/0022-2836(68)90205-2) [DOI] [PubMed] [Google Scholar]
  • 50.Howell SL. 1984. The mechanism of insulin-secretion. Diabetologia 26, 319-327. ( 10.1007/BF00266030) [DOI] [PubMed] [Google Scholar]
  • 51.Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V. 1980. Continuous, clonal, insulin-secreting and somatostatin-secreting cell-lines established from a transplantable rat islet cell tumor. Proc. Natl Acad. Sci. USA 77, 3519-3523. ( 10.1073/pnas.77.6.3519) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.McClenaghan NH, Elsner M, Tiedge M, Lenzen S. 1998. Molecular characterization of the glucose-sensing mechanism in the clonal insulin-secreting BRIN-BD11 cell line. Biochem. Biophys. Res. Commun. 242, 262-266. ( 10.1006/bbrc.1997.7947) [DOI] [PubMed] [Google Scholar]
  • 53.Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. 2004. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145, 667-678. ( 10.1210/en.2003-1099) [DOI] [PubMed] [Google Scholar]
  • 54.Asfari M, Janjic D, Meda P, Li GD, Halban PA, Wollheim CB. 1992. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130, 167-178. ( 10.1210/en.130.1.167) [DOI] [PubMed] [Google Scholar]
  • 55.Miyazaki JI, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura KI. 1990. Establishment of a pancreatic β cell line that retains glucose-inducible insulin-secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126-132. ( 10.1210/endo-127-1-126) [DOI] [PubMed] [Google Scholar]
  • 56.Asai S, Moravcová J, Žáková L, Selicharová I, Hadravová R, Brzozowski AM, Nováček J, Jiráček J. 2022. Characterisation of insulin crystalline form in isolated β-cell secretory granules. Figshare. ( 10.6084/m9.figshare.c.6328877) [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. Asai S, Moravcová J, Žáková L, Selicharová I, Hadravová R, Brzozowski AM, Nováček J, Jiráček J. 2022. Characterisation of insulin crystalline form in isolated β-cell secretory granules. Figshare. ( 10.6084/m9.figshare.c.6328877) [DOI] [PMC free article] [PubMed]

Data Availability Statement

The data are provided in electronic supplementary material [56].


Articles from Open Biology are provided here courtesy of The Royal Society

RESOURCES